This is a book review of the new volume by Peter C. Gøtzsche, Deadly Medicines and Organized Crime: How Big Pharma Has Corrupted Healthcare (New York: Radcliffe Publishing, 2013). It presents the evidence for an aspect of the pharmaceutical industry that almost never gets discussed, but that you should be aware of.
Deadly Medicines: Over the Top or Overdue Wake-up Call?
Ethics, Medicine, and Pharma
The book features Forewords by two heavy hitters, Richard Smith, former editor of BMJ, and Drummond Rennie, long-time deputy editor of JAMA. If you read between the lines, the two editors both convey more or less the same message-this guy comes across as a raving lunatic, but it would be a shame if you were put off by that tone, because he actually has something important to say.
By way of the lunacy quotient, I append a representative list of quotes:
‘In the United States and Europe, drugs are the third leading cause of death after heart disease and cancer.”(1)
‘The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs. Blatant lies that-in all the cases I have studied-have continued after the statements were proven wrong.”(2)
‘The book addresses a general system failure caused by widespread crime, corruption and impotent drug regulation in need of radical reforms. Some readers will find my book one-sided and polemic, but there is little point in describing what goes well in a system that is out of control. If a criminologist undertakes a study of muggers, no one expects a ‘balanced’ account mentioning that many muggers are good family men.”(2)
‘I dedicate this book to the many honest people working in the drug industry who are equally appalled as I am about the repetitive criminal actions of their superiors and their harmful consequences for the patients and our national economies. Some of these insiders have told me they would wish their top bosses were sent to jail, as the threat of this is the only thing that might deter them from continuing committing crimes.”(3)
‘[Industry] clinical trials are rarely research in the true sense of the word…it is marketing disguised as research. The trials are often flawed by design, additional flaws are introduced during data analysis, and the misleading results are spun to make sure that whatever an honest trial might have shown, the trial concludes something that is useful for boosting sales.”(87)
